Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT01854983 |
Date of registration:
|
14/05/2013 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Significance of Fluorescence Colposcopy With Autofluorescence Imaging for Cervical Cancer
|
Scientific title:
|
Clinical Trial to Access Significance of Fluorescence Colposcopy With Autofluorescence Imaging for the Screening of Cervical Cancer |
Date of first enrolment:
|
May 2013 |
Target sample size:
|
80 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT01854983 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Korea, Republic of
| | | | | | | |
Contacts
|
Name:
|
Jeong-Yeol Park, M.D., Ph.D. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Asan Medical Center |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. age : 20-65 years
2. abnormal cervical papanicolaou smear , no other specific cervical disease
3. subject to colposcopic biopsy or LEEP
4. signed voluntarily to informed concents with full knowledge after explanation abot
objective, method, contents
Exclusion Criteria:
1. pregnant women
2. porphyria
3. severe cervical bleeding
4. genital chlamydia, gonorrhea infection
5. other drug user with possible interaction (e.g. photosensitizer)
6. no informed consent
Age minimum:
20 Years
Age maximum:
65 Years
Gender:
Female
|
Health Condition(s) or Problem(s) studied
|
Cervical Cancer
|
Primary Outcome(s)
|
fluorescence colposcopic result
[Time Frame: 2weeks after fluorescence colposcopy]
|
Secondary ID(s)
|
2012-0693
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|